{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:49:40Z","timestamp":1791575380672,"version":"4.3.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,9]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\u03b2-Thalassemia trait and myelodysplastic syndrome (MDS) may occur in the same patient. In patients with MDS and microcytosis, an important diagnostic consideration is whether the thalassemic phenotype represents a preexisting hereditary disorder or an acquired abnormality related to the myeloid clone. We report on a patient with SF3B1-mutated MDS and \u03b2-thalassemia trait, supported by longitudinal hematologic and molecular findings, and discuss the diagnostic distinction between these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>An 81-year-old male presented with fatigue and fever, and laboratory investigations revealed microcytic anemia. Further evaluation identified SF3B1-mutated MDS with concomitant \u03b2-thalassemia trait.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was diagnosed with SF3B1-mutated MDS with concomitant \u03b2-thalassemia trait based on bone marrow morphology and molecular studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions and outcomes:<\/jats:title>\n                    <jats:p>Following conservative management, the patient was discharged. During the available follow-up period, the patient remained clinically stable across three outpatient visits for complete blood count monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case illustrates the importance of distinguishing hereditary \u03b2-thalassemia from acquired thalassemic phenotypes in patients with MDS and microcytosis. Longitudinal hematologic history, hemoglobin analysis, and molecular testing can help determine whether microcytosis predates the clonal myeloid disorder. The available case-based literature does not permit a reliable estimate of the prevalence of this co-occurrence or comparison with a control population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000051047","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:00:10Z","timestamp":1791572410000},"page":"e51047","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["SF3B1-mutated MDS coexisting with \u03b2-thalassemia trait"],"prefix":"10.1097","volume":"105","author":[{"given":"Zenghui","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghe","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7549-2369","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1182\/blood.2023020078","article-title":"Diagnosis and classification of myelodysplastic syndromes.","volume":"142","author":"Hasserjian","year":"2023","journal-title":"Blood"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tibs.2013.06.011","article-title":"The chromatin remodeller ATRX: a repeat offender in human disease.","volume":"38","author":"Clynes","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"1434398","DOI":"10.3389\/fmolb.2024.1434398","article-title":"Mutant ATRX: pathogenesis of ATRX syndrome and cancer.","volume":"11","author":"Yuan","year":"2024","journal-title":"Front Mol Biosci"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/ng1213","article-title":"Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).","volume":"34","author":"Gibbons","year":"2003","journal-title":"Nat Genet"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2003-09-3360","article-title":"Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.","volume":"103","author":"Steensma","year":"2004","journal-title":"Blood"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ajh.24073","article-title":"Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.","volume":"90","author":"Herbaux","year":"2015","journal-title":"Am J Hematol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/03630268309038402","article-title":"Erythroleukemia manifesting delta beta-thalassemia.","volume":"7","author":"Markham","year":"1983","journal-title":"Hemoglobin"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2141.1991.tb08017.x","article-title":"Acquired beta thalassaemia trait in MDS.","volume":"79","author":"Hoyle","year":"1991","journal-title":"Br J Haematol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1002\/ajh.24400","article-title":"Myelodysplastic syndrome associated with acquired beta thalassemia: \u201cBTMDS\u201d.","volume":"91","author":"Brunner","year":"2016","journal-title":"Am J Hematol"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1016\/j.leukres.2010.03.012","article-title":"Mixed myelodysplastic syndrome associated with \u03b2-thalassemia intermedia.","volume":"34","author":"Gologan","year":"2010","journal-title":"Leuk Res"},{"key":"R12-20261009","first-page":"32","article-title":"A rare case of myelodysplastic syndrome with ring sideroblasts, SF3B1 and TET2 mutations in a patient with beta thalassemia trait.","volume":"10","author":"Ahlstedt","year":"2017","journal-title":"N Am J Med Sci"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.46701\/APJBG.2019022019120","article-title":"Myelodysplastic syndrome with ring sideroblasts, SF3B1 mutation and beta thalassemia trait: a case of report.","volume":"3","author":"Hojat","year":"2019","journal-title":"Blood Genomics"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ajh.26856","article-title":"\u201cDouble-hit\u201d ineffective erythropoiesis \u2013 concurrent \u03b2-thalassemia with \u03b1-gene triplication and myelodysplastic syndrome with SF3B1 mutation.","volume":"98","author":"Chen","year":"2023","journal-title":"Am J Hematol"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data.","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes.","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes.","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2004-07-2792","article-title":"Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies.","volume":"105","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.3324\/haematol.13405","article-title":"Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.","volume":"93","author":"Mufti","year":"2008","journal-title":"Haematologica"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/leu.2014.331","article-title":"Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.","volume":"29","author":"Dolatshad","year":"2015","journal-title":"Leukemia"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/leu.2016.149","article-title":"Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes.","volume":"30","author":"Dolatshad","year":"2016","journal-title":"Leukemia"},{"key":"R24-20261009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:00:13Z","timestamp":1791572413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000051047"}},"subtitle":["A case report and literature review focused on diagnostic distinction from acquired \u03b2-thalassemia"],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":23,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000051047","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"assertion":[{"value":"2025-12-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}